Skip Navigation

Cardiovascular Research 2006 70(2):335-345; doi:10.1016/j.cardiores.2006.01.018
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Valverde, C. A.
Right arrow Articles by Mattiazzi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valverde, C. A.
Right arrow Articles by Mattiazzi, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2006, European Society of Cardiology

Phospholamban phosphorylation sites enhance the recovery of intracellular Ca2+ after perfusion arrest in isolated, perfused mouse heart

Carlos A. Valverdea,*, Cecilia Mundiña-Weilenmanna, Mariano Reyesb, Evangelia G. Kraniasc, Ariel L. Escobarb and Alicia Mattiazzia

aCentro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, 60 y 120, (1900) La Plata, Argentina
bDepartment of Physiology, Texas Tech University, Health Science Center, Lubbock, TX 79430, USA
cDepartment of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0575, USA

* Corresponding author. Tel./fax: +54 221 483 4833. Email address: valverdeca{at}atlas.med.unlp.edu.ar

Objective To investigate the importance of the phosphorylation of Ser16 and Thr17 sites of phospholamban (PLN) on intracellular Ca2+ (CaiFormula) handling and contractile recovery of the stunned myocardium.

Methods CaiFormula (Rhod-2, pulsed local-field fluorescence microscopy) and contractility (isovolumic left ventricular developed pressure, LVDP) were simultaneously measured in Langendorff perfused hearts from transgenic mice expressing either intact PLN (PLN-WT) or PLN with both phosphorylation sites mutated to Ala (PLN-DM), subjected to 12 min of global ischemia followed by a reperfusion period of 30 min.

Results Pre-ischemic values of CaiFormula and LVDP were similar in both groups. In PLN-WT, a transient increase in Thr17 phosphorylation at early reperfusion preceded a recovery of Ca2+ transient amplitude, virtually completed by the end of reperfusion. LVDP at 30 min reperfusion was 67.9±7.6% of pre-ischemic values, n=14. In contrast, in PLN-DM, there was a poor recovery of CaiFormula transient amplitude and LVDP was significantly lower (28.3±6.7%, n=11, 30 min reperfusion) than in PLN-WT hearts. Although myofilament Ca2+ responsiveness and troponin I (TnI) degradation did not differ between groups, the episodes of mechanical alternans, typical of CaiFormula overload, were significantly prolonged in PLN-DM vs. PLN-WT hearts.

Conclusions PLN phosphorylation appears to be crucial for the mechanical and CaiFormula recovery during stunning and protective against the mechanical abnormalities typical of CaiFormula overload. The importance of PLN phosphorylation would primarily reside in the Thr17 residue, which is phosphorylated during the critical early phase of reperfusion. Our results emphasize that, although ablation of PLN phosphorylation does not affect basal contractility, it does alter Ca2+ handling and mechanical performance under stress situations.

KEYWORDS Phospholamban phosphorylation residues; Phospholamban mutants; Intracellular calcium; Ischemia–reperfusion; Myofibrillar proteins


Time for primary review 22 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Circ Heart FailHome page
C. M. Sag, D. P. Wadsack, S. Khabbazzadeh, M. Abesser, C. Grefe, K. Neumann, M.-K. Opiela, J. Backs, E. N. Olson, J. H. Brown, et al.
Calcium/Calmodulin-Dependent Protein Kinase II Contributes to Cardiac Arrhythmogenesis in Heart Failure
Circ Heart Fail, November 1, 2009; 2(6): 664 - 675.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Nicolaou, P. Rodriguez, X. Ren, X. Zhou, J. Qian, S. Sadayappan, B. Mitton, A. Pathak, J. Robbins, R. J. Hajjar, et al.
Inducible Expression of Active Protein Phosphatase-1 Inhibitor-1 Enhances Basal Cardiac Function and Protects Against Ischemia/Reperfusion Injury
Circ. Res., April 24, 2009; 104(8): 1012 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. E. Bondarenko and R. L. Rasmusson
Simulations of propagated mouse ventricular action potentials: effects of molecular heterogeneity
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1816 - H1832.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Mattiazzi, L. Vittone, and C. Mundina-Weilenmann
Ca2+/calmodulin-dependent protein kinase: A key component in the contractile recovery from acidosis
Cardiovasc Res, March 1, 2007; 73(4): 648 - 656.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Vila-Petroff, M. A. Salas, M. Said, C. A. Valverde, L. Sapia, E. Portiansky, R. J. Hajjar, E. G. Kranias, C. Mundina-Weilenmann, and A. Mattiazzi
CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury
Cardiovasc Res, March 1, 2007; 73(4): 689 - 698.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Garcia-Dorado, J. Vinten-Johansen, and H. M. Piper
Bringing preconditioning and postconditioning into focus
Cardiovasc Res, May 1, 2006; 70(2): 167 - 169.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.